Induction Chemotherapy and Toripalimab for Larynx Preservation in Resectable Laryngeal/Hypopharyngeal Carcinoma

Clinical trial NCT04995120 · UNKNOWN

Trial details

NCT number: NCT04995120
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Laryngeal Cancer Hypopharynx Cancer Laryngeal Neoplasms

Start date: 2021-04-07
Primary completion: 2024-12-31
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.